Skip to content

Cvb1nabsp2titrsernt

Published: August 9, 2026Updated: August 16, 2026

This blood test measures neutralizing antibodies against Coxsackievirus B1 to help diagnose heart infections like myocarditis.

Quick summary

{"Detects antibodies your body makes to fight Coxsackievirus B1","Used to determine if you have a recent or ongoing heart infection","A second blood sample is compared to the first to check for rising antibody levels","Results help doctors diagnose viral myocarditis","The test requires two blood draws spaced apart to confirm infection"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
24180-2
Short code
CVB1 Neut Ab Titer
Synonyms
CV B1 NAb sp2 Titr Ser Nt
Category
cardiac
Sample
serum
Container
Serum separator tube (SST) or plain red top tube
Units
N/A
Ref low
8
Fasting
false
Population
adult
Sex
all
Age range
≥ 0 years
Method
Virus Neutralization Test
CPT
86622
SNOMED
371949004
Specimen volume
1-2 mL of serum
Stability
Serum stable at 2-8°C for 7 days; at -20°C for longer storage; avoid repeated freeze-thaw cycles
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
72–168 hours
Order
routine

What is this test?

The Coxsackievirus B1 neutralizing antibody test is a blood test that detects antibodies your immune system produces in response to Coxsackievirus B1 infection. This virus is part of the enterovirus family and can cause myocarditis, an inflammation of the heart muscle. The '2nd specimen' means this is a follow-up test—the first sample was taken when you first got sick, and this second sample is taken later to see if your antibody levels have increased, which confirms a recent infection.

Why do I need this test?

Your doctor ordered this test if you have symptoms of myocarditis or have been exposed to Coxsackievirus B1. Symptoms may include chest pain, shortness of breath, fatigue, fever, or irregular heartbeat. This test helps determine whether a viral infection is affecting your heart. The comparison between your first and second blood samples (showing a 4-fold or greater increase in antibody levels) provides strong evidence of a recent Coxsackievirus B1 infection.

How is the test performed?

A healthcare professional will draw blood from a vein in your arm, usually in the morning. You may need to have two blood draws—your first (acute phase) sample and this second (convalescent phase) sample, typically taken 2-4 weeks apart. The blood is sent to a laboratory where technicians mix it with the Coxsackievirus B1 virus to see if your antibodies can neutralize (disable) the virus. The results are reported as a titer, which indicates how diluted your blood can be and still neutralize the virus.

What do the results mean?

If your second specimen shows a 4-fold or greater increase in neutralizing antibody levels compared to your first sample, it indicates a recent or ongoing Coxsackievirus B1 infection. This is particularly important if you have heart symptoms, as it suggests the virus may be causing myocarditis. A negative or unchanged result suggests no recent infection. Your doctor will interpret these results along with your symptoms, physical exam, and other test results (like ECG or echocardiogram) to make a diagnosis.

Are there any risks?

The risks are minimal and similar to any routine blood draw. You may experience slight pain, bruising, or dizziness. Serious complications like infection or excessive bleeding are rare. The benefits of obtaining a proper diagnosis for your heart symptoms far outweigh these minor risks.

Reference range

Negative: <1:8; Positive: ≥1:8; Four-fold rise in titer between acute and convalescent specimens indicates recent infectionN/A

Specimen: serum

No special preparation required. This is a second (convalescent) specimen typically collected 2-4 weeks after the acute specimen for seroconversion testing.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Frequently asked questions

Do I need to fast before this test?
No, you do not need to fast. You can eat and drink normally before the blood draw. However, follow any specific instructions your doctor gives you.
How long does it take to get results?
Neutralizing antibody tests are specialized and may take 1-2 weeks to complete. The laboratory needs time to grow the virus and perform the neutralization assay properly.
What happens if my test is positive?
A positive result showing rising antibody levels means you have a recent Coxsackievirus B1 infection. Your doctor will discuss treatment options, which typically include rest, avoiding exercise, and sometimes medications. Most people recover fully with proper care.
Can this test tell me if I have myocarditis?
This test confirms Coxsackievirus B1 infection but does not directly diagnose myocarditis. Your doctor will use this result along with other tests (like echocardiogram, ECG, and blood tests for heart enzymes) to determine if your heart is affected.
Is Coxsackievirus B1 the same as COVID-19?
No, Coxsackievirus B1 is a different virus. It is an enterovirus, while COVID-19 is caused by the SARS-CoV-2 coronavirus. Both can cause heart problems, but they are distinct viruses.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy